CRP and COVID-19: Studies have demonstrated a connection between the early initiation of Anakinra therapy in hospitalized COVID-19 patients and the positive dynamics of examined biomarkers, including the reduction in CRP, ferritin, D-dimer, and NLR [32,33,34,35,36,37].